Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-12-06 Sale |
2024-12-10 5:03 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
866 | $8.06 | $6,980 | 17,918 (Direct) |
View |
2024-07-11 Sale |
2024-07-15 5:29 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
11,945 | $15.97 | $190,747 | 102,342 (Direct) |
View |
2023-12-05 Sale |
2023-12-06 8:24 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Sr. VP & CMO |
534 | $9.63 | $5,142 | 26,466 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-12 Option Award |
2025-02-14 4:42 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
9,750 | $0 | 24,807 (Direct) |
View |
2025-02-12 Tax Withholding |
2025-02-14 4:42 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
2,861 | $5.59 | 24,807 (Direct) |
View |
2024-11-27 Option Award |
2024-11-27 5:04 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
87,000 | $0 | 87,000 (Direct) |
View |
2023-08-08 Tax Withholding |
2024-08-09 5:24 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
1,467 | $17.23 | 18,784 (Direct) |
View |
2024-08-08 Tax Withholding |
2024-08-09 5:24 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
1,466 | $12.73 | 18,784 (Direct) |
View |
2024-07-15 Exercise |
2024-07-15 5:29 pm |
N/A 2033-11-22 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
5,375 | $0 | 102,342 (Direct) |
View |
2024-07-15 Exercise |
2024-07-15 5:29 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
5,375 | $8.99 | 102,342 (Direct) |
View |
2024-02-12 Option Award |
2024-02-14 8:15 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
2,576 | $0 | 28,287 (Direct) |
View |
2024-02-12 Tax Withholding |
2024-02-14 8:15 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
755 | $12.41 | 28,287 (Direct) |
View |
2023-11-22 Option Award |
2023-11-22 5:10 pm |
N/A 2033-11-22 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Sr. VP & CMO |
86,000 | $0 | 86,000 (Direct) |
View |
2022-11-23 Option Award |
2022-11-28 6:28 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
22,000 | $0 | 42,000 (Direct) |
View |
2022-08-08 Option Award |
2022-08-11 4:32 pm |
N/A 2032-08-08 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
95,000 | $0 | 95,000 (Direct) |
View |